Although the ictal increase in blood levels of CGRP tends to be smaller than in migraine, there is a convincing physiological rationale for the utility of anti-CGRP/rec mAbs in cluster headache (CH) [122]. The gene discussed is CALCA; the disease is migraine disorder.